85 related articles for article (PubMed ID: 25743778)
1. Intraocular pressure after intravitreal injection of dexamethasone implant for macular edema resulting from retinal vein occlusion.
Caillaux V; Valtot F; Souied EH; Mimoun G
Eur J Ophthalmol; 2015; 25(5):454-8. PubMed ID: 25743778
[TBL] [Abstract][Full Text] [Related]
2. Effect of dexamethasone intravitreal implant (Ozurdex®) on corneal endothelium in retinal vein occlusion patients : Corneal endothelium after dexamethasone implant injection.
Güler HA; Örnek N; Örnek K; Büyüktortop Gökçınar N; Oğurel T; Yumuşak ME; Onaran Z
BMC Ophthalmol; 2018 Sep; 18(1):235. PubMed ID: 30180837
[TBL] [Abstract][Full Text] [Related]
3. Incidence and treatment approach of intraocular pressure elevation after various types of local steroids for retinal diseases.
Wykrota AA; Abdin AD; Munteanu C; Löw U; Seitz B
Graefes Arch Clin Exp Ophthalmol; 2023 Dec; 261(12):3569-3579. PubMed ID: 37432451
[TBL] [Abstract][Full Text] [Related]
4. Effect of intralenticular dexamethasone implant: A case report.
Carnevali A; Taloni A; Gatti V; Lamonica L; Oliverio F; Randazzo G; Scorcia V
Eur J Ophthalmol; 2024 Jan; 34(1):NP80-NP83. PubMed ID: 37165519
[TBL] [Abstract][Full Text] [Related]
5. Baseline intraocular pressure: an independent risk factor in severe steroid-induced ocular hypertension after intravitreal dexamethasone implant.
Cho WJ; Lee JM; Bae HW; Kim CY; Seong GJ; Choi W
Graefes Arch Clin Exp Ophthalmol; 2024 Apr; 262(4):1231-1243. PubMed ID: 37930443
[TBL] [Abstract][Full Text] [Related]
6. [Late steroid-induced ocular hypertension after intravitreal dexamethasone implants: A series of 20 cases].
Billant J; Douma I; Agard E; Levron A; Bouvarel H; Leroux P; Badri Y; Dot C
J Fr Ophtalmol; 2023 Nov; 46(9):1039-1046. PubMed ID: 37758545
[TBL] [Abstract][Full Text] [Related]
7. The effects of intravitreal injections on intraocular pressure and retinal nerve fiber layer: a systematic review and meta-analysis.
de Vries VA; Bassil FL; Ramdas WD
Sci Rep; 2020 Aug; 10(1):13248. PubMed ID: 32764619
[TBL] [Abstract][Full Text] [Related]
8. Effect of twisting of intravitreal injections on ocular bio-mechanics: a novel insight to ocular surgery.
Siddharth A; Bhandari A; Singh SS; Udai AD
Biomech Model Mechanobiol; 2024 Jun; 23(3):1013-1030. PubMed ID: 38361086
[TBL] [Abstract][Full Text] [Related]
9. Comparison of intravitreal bevacizumab and dexamethasone implant for the treatment of macula oedema associated with branch retinal vein occlusion.
Kim M; Lee DH; Byeon SH; Koh HJ; Kim SS; Lee SC
Br J Ophthalmol; 2015 Sep; 99(9):1271-6. PubMed ID: 25777815
[TBL] [Abstract][Full Text] [Related]
10. THE OMAR STUDY: Comparison of Ozurdex and Triamcinolone Acetonide for Refractory Cystoid Macular Edema in Retinal Vein Occlusion.
Ozkok A; Saleh OA; Sigford DK; Heroman JW; Schaal S
Retina; 2015 Jul; 35(7):1393-400. PubMed ID: 25748280
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal Aflibercept Injection in Patients with Myopic Choroidal Neovascularization: The MYRROR Study.
Ikuno Y; Ohno-Matsui K; Wong TY; Korobelnik JF; Vitti R; Li T; Stemper B; Asmus F; Zeitz O; Ishibashi T;
Ophthalmology; 2015 Jun; 122(6):1220-7. PubMed ID: 25745875
[TBL] [Abstract][Full Text] [Related]
12. Rescue therapy with intravitreal aflibercept for choroidal neovascularization secondary to choroidal osteoma non-responder to intravitreal bevacizumab and ranibizumab.
Saitta A; Nicolai M; Neri P; Reibaldi M; Giovannini A; Mariotti C
Int Ophthalmol; 2015 Jun; 35(3):441-4. PubMed ID: 25761547
[TBL] [Abstract][Full Text] [Related]
13. Change in vision after retinal pigment epithelium tear following the use of anti-VEGF therapy for age-related macular degeneration.
Durkin SR; Farmer LD; Kulasekara S; Gilhotra J
Graefes Arch Clin Exp Ophthalmol; 2016 Jan; 254(1):1-6. PubMed ID: 25749721
[TBL] [Abstract][Full Text] [Related]
14. Darapladib, a lipoprotein-associated phospholipase A2 inhibitor, in diabetic macular edema: a 3-month placebo-controlled study.
Staurenghi G; Ye L; Magee MH; Danis RP; Wurzelmann J; Adamson P; McLaughlin MM;
Ophthalmology; 2015 May; 122(5):990-6. PubMed ID: 25749297
[TBL] [Abstract][Full Text] [Related]
15. Effect of photocoagulation of ischemic areas to prevent recurrence of diabetic macular edema.
Tan CS; Chew MC; Lim LW; Sadda SR
Invest Ophthalmol Vis Sci; 2015 Mar; 56(3):1609. PubMed ID: 25745079
[No Abstract] [Full Text] [Related]
16. Changes in choroidal thickness after intravitreal dexamethasone implant injection in retinal vein occlusion.
Lee EK; Han JM; Hyon JY; Yu HG
Br J Ophthalmol; 2015 Nov; 99(11):1543-9. PubMed ID: 25883084
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Response to Ranibizumab Therapy following Bevacizumab Treatment Failure in Eyes with Diabetic Macular Edema.
Hanhart J; Chowers I
Case Rep Ophthalmol; 2015; 6(1):44-50. PubMed ID: 25802504
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal dexamethasone implant for cystoid macular edema and inflammation after scleral buckling.
Bonfiglio V; Fallico MR; Russo A; De Grande V; Longo A; Uva MG; Reibaldi M; Avitabile T
Eur J Ophthalmol; 2015 Jul; 25(5):e98-e100. PubMed ID: 25790811
[TBL] [Abstract][Full Text] [Related]
19. What have we learnt about the management of diabetic macular edema in the antivascular endothelial growth factor and corticosteroid era?
Agarwal A; Sarwar S; Sepah YJ; Nguyen QD
Curr Opin Ophthalmol; 2015 May; 26(3):177-83. PubMed ID: 25784111
[TBL] [Abstract][Full Text] [Related]
20. Pro-Permeability Factors After Dexamethasone Implant in Retinal Vein Occlusion; the Ozurdex for Retinal Vein Occlusion (ORVO) Study.
Campochiaro PA; Hafiz G; Mir TA; Scott AW; Sophie R; Shah SM; Ying HS; Lu L; Chen C; Campbell JP; Kherani S; Zimmer-Galler I; Wenick A; Han I; Paulus Y; Sodhi A; Wang G; Qian J
Am J Ophthalmol; 2015 Aug; 160(2):313-321.e19. PubMed ID: 25908486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
